Vicente LLP Federal and International Cannabis and Psychedelics Law and Policy Update: November 2023
Nov 10, 2023
Federal and international law and policy insights, news and events from Vicente LLP.
Nov 10, 2023
Federal and international law and policy insights, news and events from Vicente LLP.
By Jason Adelstone
Nov 6, 2023
While the cannabis industry in the United States awaits a marijuana scheduling decision from the DEA, many countries around the world continue to move forward with liberalizing their cannabis policies as a superior method of promoting the health and welfare of their citizens. In this blog post, we’ll take a closer look at five countries poised to make waves in the cannabis landscape in 2024, including Germany, Thailand, Colombia, the Czech Republic, and Switzerland.
Oct 26, 2023
This recorded session features members of Vicente LLP’s Federal and International Law and Policy practice group and London cannabis attorney Robert Jappie of Fieldfisher sharing insights into what’s happening with cannabis and hemp-derived cannabinoids across the pond and opportunities for US operators and investors.
By Katelin Edwards, Andrea Golan
Aug 1, 2023
Between an unfavorable court ruling and an uninspiring 2021 legislative session, not to mention a major drought impacting all Texas crops, things were not looking good for hemp in Texas going into the 2023 legislative session. Then, many of the promising bills introduced in the 2023 legislative session were unsuccessful. Where does the Texas hemp market go from here? Read this article for four predictions from Vicente's hemp team.
By Catie Wightman
Feb 13, 2023
In recent years, several CBD companies faced product liability lawsuits brought by consumers. Many of these cases were dismissed without prejudice or stayed until the FDA takes action to regulate CBD products. Now that the FDA said it will not take action to regulate CBD, could these cases be revived?
By Catie Wightman
Feb 9, 2023
With recent announcements from the FDA pushing CBD and hemp-derived products further into a legal gray area, can veterinarians recommend or sell these products for pets?
By Catie Wightman
Jan 17, 2023
The SB 22-205 Intoxicating Hemp Task Force's final report makes legislative and rule recommendations concerning the regulation of intoxicating and synthetic hemp products in Colorado. We compiled 10 key takeaways for hemp industry stakeholders.
By Catie Wightman
Jan 3, 2023
In this two-part VS Insights series, we discuss the potential legal implications for veterinarians to consider regarding cannabis and hemp products. This first article focuses on cannabis products, while part two focuses on hemp and hemp-derived products.
Dec 15, 2022
Watch as Vicente Sederberg LLP and EARTH Law LLC discuss the regulatory approaches for intoxicating hemp in Colorado, Oregon and California, and our projections for the future
By Catie Wightman, Michelle Bodian
Nov 30, 2022
On November 21, 2022, the FDA issued five warning letters to companies selling CBD, Delta-8, and other hemp products for humans and pets.
By Michelle Bodian, Catie Wightman
Nov 1, 2022
Planning to ship hemp or hemp-derived CBD products? Read this first.
By Shawn Hauser, Catie Wightman, Ariane Beckman
Sep 20, 2022
Like the US, regulators in the UK are struggling to find ways to best regulate CBD and other hemp-derived products—frustrating hemp businesses across the globe. Read this VS Insights article to learn how the UK is currently regulating CBD and key findings and recommendations from the ACMD's Consumer CBD Products Report.
By Catie Wightman, Ariane Beckman
Aug 11, 2022
The FDA is cracking down on companies making unlawful drug or disease claims about their products relating to CBD by recently issuing several warning letters to address these compliance violations.
By Catie Wightman, Shawn Hauser
Jun 16, 2022
We recently hosted a webinar exploring intoxicating hemp-derived products. Read this for key takeaways from the session.
By Michelle Bodian, Shawn Hauser, Catie Wightman
May 5, 2022
For the first time ever, the FDA issued warning letters to companies selling products containing hemp-derived Delta-8 THC. Notably, this is the first time the FDA has specifically enforced against Delta-8 products. Read this for key takeaways from these warning letters.
Apr 4, 2022
Update on hemp-related legislation and rulemaking, regulatory changes, and other noteworthy hemp news and events.
Apr 1, 2022
Watch this session exploring trending topics in hemp. During the session, members of our hemp team dive into the legality, regulation, and lawsuits surrounding minor cannabinoids, current federal hemp legislation, and what we expect and hope to see in the 2023 Farm Bill.
Mar 4, 2022
VS counsel Shane Pennington is joining Dr. Sue Sisley and attorney Matt Zorn on Tuesday, March 15 at 10 a.m. CT for the SXSW session "Sue 'n the DEA: Breaking the 50-year NIDA Monopoly."
By Michelle Bodian, Catie Wightman
Dec 17, 2021
After several extensions, the 2014 Farm Bill is finally set to expire on Dec. 31. What's next for state hemp programs and what are the 2018 Farm Bill's notable requirements?
Oct 19, 2021
Watch this recorded session for an update on recent changes in the Colorado market from members of our Colorado regulatory, corporate, and hemp teams and special guest Christopher Stefan of Cannabis Capital Advisors.
By Shane Pennington
Sep 13, 2021
Texas has allowed hemp cultivation and state-based manufacturing, distribution, and retail sale of hemp and consumable hemp products since 2019—but only if the products weren’t intended for smoking. This prohibition on a product with such high value for hemp farmers—and soaring consumer demand—was sure to make waves.
Jul 22, 2021
VS's Jason Adelstone, Catie Wightman and Genevieve Meehan will participate in a free expungement clinic to be held on July 31, 2021 in Denver.
By Catie Wightman, Jace Pohlman
Jul 13, 2021
Move over CBD; there are new cannabinoids in town. CBD has been the most sought-after and utilized hemp-derived cannabinoid in consumer products, but due in part to technological advances, various other hemp-derived cannabinoids, like CBG, CBN, and CBC, are now creating a well-deserved buzz.
By Caitlin Wightman, Michelle Bodian, Jace Pohlman
Jun 15, 2021
Over the first half of 2021, many states passed laws, implemented, or proposed new regulations regarding hemp cultivation, processing, and CBD products. These changes range from updates to testing, labeling, and packaging requirements, to adjustments in license requirements and limits on the types of hemp-derived products that can be sold.
By Dwight Clark, Shawn Hauser, Jerrico Perez
May 18, 2021
Championing medical cannabis legislation would likely help Republican lawmakers attract younger supporters, appeal to more unaffiliated voters, and remain competitive.
Apr 23, 2021
Shawn Hauser and Jerrico Perez are slated to moderate two can't-miss discussions with Beto O'Rourke and Joe Jaworski on April 27 and 28 during Willie Nelson's first annual Luck Summit.
By Shawn Hauser
Mar 23, 2021
While we move closer to federal legalization, the great state of Texas remains an untapped major market—ripe for reform, but hard to move. Read this for opportunities to help bring about more responsible cannabis policies in the Lone Star State.
Mar 1, 2021
On March 6, 2021, Andrew Livingston will participate in the virtual event "Economics of a Regulated Cannabis Market," presented by the nonprofit cannabis advocacy organization Foundation for an Informed Texas.
By Charles Alovisetti
Jan 25, 2021
Like anything in the cannabis industry, getting a debt deal done requires navigating unique regulatory challenges. Here are seven regulatory considerations that cannabis borrowers and lenders should keep in mind when pursuing a debt transaction.
By Caitlin Wightman, Michelle Bodian
Dec 23, 2020
On December 17, 2020, the Federal Trade Commission announced robust enforcement actions against companies making deceptive claims about CBD and CBG products.
By Vicente Sederberg LLP
Dec 1, 2020
For our 10th anniversary, we take a look back at VS's history of leadership in cannabis law, the marijuana and hemp industries, and drug policy reform.
Nov 25, 2020
Update on hemp legislation and rulemaking, regulatory changes, and other noteworthy hemp news and events.
By Catie Wightman
Nov 16, 2020
If you are selling CBD products—even products sold exclusively online—you must follow retailer requirements in the states where you sell products (i.e., where your customers are located).
By Andrew Livingston, Shawn Hauser, Dwight Clark, Mason Tvert
Oct 21, 2020
Texas could see more than half a billion dollars in annual tax revenue and tens of thousands of new jobs if it legalizes cannabis, a VS analysis finds.
By Charles Alovisetti, Elliot Choi, Sahar Ayinehsazian
Sep 18, 2020
Raising private capital continues to be a challenge for the nascent cannabis industry, but there are proactive steps companies can take to maximize the chance of a successful raise.
By Shawn Hauser
May 19, 2020
With its incredible farming communities, over 100 million acres of farmland, and large manufacturing and research infrastructure, Texas is poised to play a significant role in the U.S. hemp industry.
Apr 20, 2020
Shawn Hauser and Dwight Clark talked about SBA loans for cannabis businesses and political advocacy during Texas NORML's 420 Stream-A-Thon.
Apr 17, 2020
Vicente Sederberg is monitoring the potential impact of the coronavirus (COVID-19) on hemp businesses, service providers, and consumers.
Mar 18, 2020
Vicente Sederberg LLP partner Shawn Hauser participated in Texas NORML's "State of Cannabis 2020." Watch it here!
Mar 12, 2020
Vicente Sederberg LLP has been working hard for many years to shape cannabis policy reform in Texas... and now we're pleased to announce that we've opened an office in Austin!
By Shawn Hauser, Partner; Courtney Barnes, Associate Attorney; Caitlin Wightman, Law Clerk
Jul 30, 2019
Here are five reasons why Texas is positioned to become one of the top hemp producers and researchers in the US, and potentially internationally.